Literature DB >> 19909886

Pathogens resistant to antibacterial agents.

Luke F Chen1, Teena Chopra, Keith S Kaye.   

Abstract

Resistance to antimicrobial drugs is increasing at an alarming rate among both gram-positive and gram-negative bacteria. Traditionally, bacteria resistant to multiple antimicrobial agents have been restricted to the nosocomial environment. A disturbing trend has been the recent emergence and spread of resistant pathogens in nursing homes, in the community, and in the hospital. This article reviews the epidemiology, molecular mechanisms of resistance, and treatment options for pathogens resistant to antimicrobial drugs.

Mesh：

Substances：

Year:  2009        PMID： 19909886     DOI： 10.1016/j.idc.2009.06.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  14 in total

1.  Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides.

Authors:  Davor Juretić; Damir Vukičević; Dražen Petrov; Mario Novković; Viktor Bojović; Bono Lučić; Nada Ilić; Alessandro Tossi
Journal:  Eur Biophys J       Date:  2011-01-28       Impact factor: 1.733

Review 2.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

3.  Development and validation of a high-throughput cell-based screen to identify activators of a bacterial two-component signal transduction system.

Authors:  Julia J van Rensburg; Kate R Fortney; Lan Chen; Andrew J Krieger; Bruno P Lima; Alan J Wolfe; Barry P Katz; Zhong-Yin Zhang; Stanley M Spinola
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

Review 4.  Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.

Authors:  Carl Llor; Lars Bjerrum
Journal:  Ther Adv Drug Saf       Date:  2014-12

5.  Δ1-pyrroline-5-carboxylate reductase as a new target for therapeutics: inhibition of the enzyme from Streptococcus pyogenes and effects in vivo.

Authors:  Giuseppe Forlani; Davide Petrollino; Massimo Fusetti; Letizia Romanini; Bogusław Nocek; Andrzej Joachimiak; Lukasz Berlicki; Paweł Kafarski
Journal:  Amino Acids       Date:  2011-07-09       Impact factor: 3.520

6.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

7.  Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.

Authors:  Ward Rodgers; Ashley D Frazier; W Scott Champney
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

8.  Comparative Study of ESBL Production Among Uropathogenic Escherichia coli Clinical Isolates from Pre- and Post-menopausal Women in Egypt.

Authors:  Ghada Hani Ali; Marwa A Yakout
Journal:  Curr Microbiol       Date:  2021-07-20       Impact factor: 2.188

9.  Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus.

Authors:  Antonio Di Grazia; Vincenzo Luca; Li-Av T Segev-Zarko; Yechiel Shai; Maria Luisa Mangoni
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

10.  Antimicrobial peptide GL13K is effective in reducing biofilms of Pseudomonas aeruginosa.

Authors:  Helmut Hirt; Sven-Ulrik Gorr
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.